Therefore, ITGA4 may influence the TME by modulating immune cell infiltration and function in various cancers, where these immune cells have complex roles in promoting or inhibiting tumors, highlighting ITGA4’s potential as a therapeutic target of controlling tumor immune suppression. This evidence concerns the gene ITGA4 and neoplasm.